Cargando…

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.

Detalles Bibliográficos
Autores principales:	Bharat, Chrianna, Gisev, Natasa, Barbieri, Sebastiano, Dobbins, Tim, Larney, Sarah, Farrell, Michael, Degenhardt, Louisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Swansea University 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644955/ http://dx.doi.org/10.23889/ijpds.v7i3.1954

Ejemplares similares

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

Five-Year Trajectories of Prescription Opioid Use
por: Gisev, Natasa, et al.
Publicado: (2023)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
por: Chaillon, Antoine, et al.
Publicado: (2021)

Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians
por: Gisev, Natasa, et al.
Publicado: (2014)

The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol
por: Gisev, Natasa, et al.
Publicado: (2018)

Risk of respiratory depression with opioids and concomitant gabapentinoids
por: Savelloni, Julie, et al.
Publicado: (2017)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Overuse of the psychoactive analgesics’ opioids and gabapentinoid drugs in patients having surgery for nerve entrapment disorders
por: Dahlin, Lars B., et al.
Publicado: (2023)

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
por: Gisev, Natasa, et al.
Publicado: (2023)

Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]
Publicado: (2018)

Opioid and gabapentinoid prescriptions in England from 2015 to 2020
por: Xia, Yixue, et al.
Publicado: (2022)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records
por: Macleod, John, et al.
Publicado: (2019)

Benzodiazepine prescribing patterns and drug overdose mortality among individuals receiving opioid analgesics
por: Park, Tae Woo, et al.
Publicado: (2015)

Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults
por: Bongiovanni, Tasce, et al.
Publicado: (2023)

Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data
por: Peacock, Amy, et al.
Publicado: (2019)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017)

Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline
por: Encinosa, William, et al.
Publicado: (2021)

Risk of Postpartum Opioid Use Disorder or Opioid Overdose After Prenatal Opioid Analgesic Use
por: Camden, Andi, et al.
Publicado: (2021)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023)

Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States
por: Bykov, Katsiaryna, et al.
Publicado: (2020)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
por: Desai, Payal H., et al.
Publicado: (2021)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

A comparison of opioids and benzodiazepines dispensing in Australia
por: Islam, M. Mofizul, et al.
Publicado: (2019)

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Tolerance to Non-Opioid Analgesics is Opioid Sensitive in the Nucleus Raphe Magnus
por: Tsagareli, Merab G., et al.
Publicado: (2011)

Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics
por: Lipiński, Piotr F. J., et al.
Publicado: (2022)

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy
por: Cheetham, Ali, et al.
Publicado: (2022)

Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery
por: Li, Guangwen, et al.
Publicado: (2013)

A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants
por: Soni, Anju, et al.
Publicado: (2021)

Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
por: Delorme, Jessica, et al.
Publicado: (2018)

Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance
por: Jeffery, Molly Moore, et al.
Publicado: (2020)

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics
por: Oh, So Yeon, et al.
Publicado: (2022)

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization
por: Delaney, Lia D., et al.
Publicado: (2022)

Pharmacogenomics and Opioid Analgesics: Clinical Implications
por: Yiannakopoulou, Eugenia
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_htot8d3l0p83nfdk72dmoi8l0e